2Liu B, Kuang A, Huang R, et al. Influence of vitamin C on salivary absorbed dose of 131 in thyroid cancer patient: a prospective, randomized, single-blind, controlled trial[J]. J Nucl Med, 2010, 51(4): 618-623.
3Zaman M, Fatima N, Padhy AK, et al. Controversies about radioactive iodine-131 remnant ablation in low risk thyroid cancers: are we near a consensus?[J]. Asian Pac J Cancer Prev, 2013, 14(11): 6209-6213.
4Lee J, Yun MJ, Nam KH, et al. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma[J]. Thyroid, 2010, 20(2): 173-179.
5Meng LW, Hu S, Huang LM, et al. Papillary thyroid cancer coexisting with thyroid tuberculosis: a case report[J]. Oncol Lett, 2014, 7(5): 1563-1565.
6Wang QC, Cheng W, Wen X, et al. Shorter distance between the nodule and capsule has greater risk of cervical lymph node metastasis in papillary thyroid carcinoma[J]. Asian Pac J Cancer Prey, 2014, 15(2): 855-860.
